Sign in now to see personalised content appear here.
You can also see your reading history and subscription details on your subscriber page.
Since 2011 there has been a total investment of £350m, split equally between the MRC, Innovate UK and leveraged funding from industry
Solid-state characterisation services will enhance complete molecule-to-product development capability
Western blotting methods have changed little in 30 years. But this technique has traditionally been restricted by issues of variability. Mats Falk, GE Healthcare Life Sciences, argues that new technologies and detection techniques herald a new era
The UK government has announced the latest winners from a fund to help rebuild British manufacturing prowess
Cost saving government policies will be the greatest barrier to future growth
Antibody-drug conjugates have provided a breakthrough in targeted medicines but ways of increasing their stability and efficacy are still required. Catalent highlights how these goals can be achieved using its SMARTag technology platform to produce site-specific ADCs
Will include new production lines and technology upgrades at four facilities worldwide
To meet changing business models and complex regulation, Diane Palmquist, VP, Manufacturing Industry Solutions at GT Nexus argues that supply chain visibility has to see fundamental change too
Merck & Co will fund the research until 30 September next year
At a recent EMA workshop held in London to discuss the lack of progress on Alzheimer’s therapies, drug developers highlighted the hurdles faced in meeting standards for drug approval
Nanolek will license the technology and manufacture a number of biologics for Green Cross
Drug discovery is brimming with innovation and technology but success is still seldom and slow. Susan Birks reports on the changing discovery landscape and how the odds can be improved